Skip to main content
Equibles
HSTI logo

HSTI · High Sierra Technologies, Inc.

Track HSTI — free

Use HSTI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HSTI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.40 At close · Aug 21
Rebalance outlook locked
Going-concern doubt — flagged Dec 15, 2023

Substantial doubt about the company's ability to continue as a going concern.

“The Company has sustained operating losses during the current year-to-date and may not achieve the level of profitable operations to sustain its activities. These factors raise substantial doubt as to its ability to obtain debt and/or equity financing and achieve profitable operations.”
View the 10-Q filed Dec 15, 2023
Market Cap
$28.90M
Shares
20.64M
Volume · Aug 21 100 Avg daily vol (4 sessions) 1031

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.40 Open$1.40 Day$1.40–1.40 Available close range$1.00–1.40 Avg vol 30d1K Short int21 · 0.0% of shares · 1.0d Short vol21% DataMar 2020–Aug 2025 Filing10-Q · Dec 15

The closing range uses available history since Feb 25, 2025; less than a full year is stored.

Latest documents

2024
2023
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$391,204
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$17,332
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.7%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Buy Momentum Neutral Sentiment Bearish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Strong Buy
50 / 200-day cross No cross
RSI (14) 51
neutral
MACD trend Positive
52-week position 100%
near high
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Neutral
1-month return −7%
trailing
YTD return +460%
this year
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Weak
EPS growth +50%
Y/Y
Free cash flow $-263.1K
Balance sheet $469.8K
net debt
Quant / Vol
risk profile
Very High
Volatility 833%
annualized · 1-yr
Max drawdown −95%
past year
ATR 19.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 2 · 3
50 / 200-day cross
No cross Neutral
RSI (14)
51 Neutral
MACD trend
Positive Bullish
52-week position
100% Bullish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $1 Now $1 · 100% Range high $1

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
HSTI
High Sierra Technologies, Inc.
this stock
$28.90M — — — 0.0%
TAK
Takeda Pharmaceutical Co Ltd
 $68.47B +37.5% — — 0.1%
GALDY
Galderma Group AG
 $54.01B +11.7% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $51.92B +42.6% +4.3% 101.1 2.4%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
 $40.66B — — — 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
21
Days to cover
1.0d
Change
+21 sh
View
Short Volume
Short vol %
21%
As of
Jul 15, 2022
Short Total
View
Fails to Deliver
FTD shares
21
Value
$84
As of
Aug 2, 2021
View
Off-Exchange
Off-exchange %
100.0%
Week of
Aug 18, 2025
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-324.0K
EPS diluted
$-0.01
View
Filings
SEC Filings
Latest
NT 10-K
Filed
Apr 1, 2024
This year
0
View

Performance

5D 20D 120D MTD YTD
HSTI +40.0% -6.7% — +3.7% +460.0%
SPY -1.5% +0.2% +7.0% +0.6% +8.4%
vs SPY +41.5% -6.9% — +3.2% +451.6%
Key facts CIK 1365388 Visit website Investor relations